胸肌梗塞的负担以及在服务不足的国家获得胸肌梗塞治疗的障碍
Diego Egas1,2, Francisco Rodriguez1, Aparna Jaswal3
1Impulso Especialistas en Enfermedades Cardíacas, Department of Cardiology and Electrophysiology, Metropolitano Hospital of Quito, Ecuador, Medical Towers Metropolitano Hospital, Office 214, Quito 170135, Ecuador.
概括
慢心率 (bradycardia) 是一个全球性的健康挑战,特别是在低收入和中等收入国家 (LMICs),缺乏足够的胸肌梗塞治疗. 解决这些差异对于公平的全球医疗保健至关重要.
科学领域:
- 心脏病学 心脏病学
- 全球健康 全球健康
- 健康 公平 卫生 公平
背景情况:
- 心,定义为异常缓慢的心率,需要有效的诊断和治疗策略.
- 在获得心肌梗塞治疗方面存在重大的全球差异,不成比例地影响低收入和中等收入国家 (LMICs).
研究的目的:
- 调查心病的全球病因和发病率.
- 为了比较高收入国家和LMICs之间的心肌梗塞患病率和管理.
- 为了识别障碍在LMICs的胸肌梗塞治疗访问和倡导公平的医疗保健.
主要方法:
- 文献综述和对全球心脏数据的比较分析.
- 检查不同经济环境中的诊断和治疗资源的可用性.
- 分析影响治疗获取的社会经济和医疗保健系统因素.
主要成果:
- 全球勃拉迪心病发病率和病因因素有很大差异.
- 与LMIC相比,高收入国家表现出与LMIC相比,更好地获得心肌梗塞诊断和治疗.
- 在LMICs的关键障碍包括有限的资源,基础设施和训练有素的员工来管理心肌梗塞.
结论:
- 解决LMICs中胸的治疗缺口是一个紧急的全球卫生优先事项.
- 公平获得心肌梗塞治疗需要有针对性的干预措施和资源配置.
- 全球合作至关重要,以克服心护理方面的差异.
相关概念视频
Decreased pulse rate
544
Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
544
Disturbances in Heart Rhythm
972
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
972
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
747
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
747
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
222
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
222
Mechanism of Cardiac Arrhythmias
925
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
925
Heart Failure Drugs: β-Blockers
342
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
342


